These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24830186)

  • 41. Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture.
    Hartogsohn I
    Transcult Psychiatry; 2022 Oct; 59(5):579-591. PubMed ID: 35818775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Psychedelic Renaissance and Its Forensic Implications.
    Holoyda B
    J Am Acad Psychiatry Law; 2020 Mar; 48(1):87-97. PubMed ID: 31948993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of alcoholism using psychedelic drugs: a review of the program of research.
    Mangini M
    J Psychoactive Drugs; 1998; 30(4):381-418. PubMed ID: 9924844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A role for psychedelics in psychiatry?
    Edwards G
    Br J Psychiatry; 2005 Nov; 187():484; author reply 484-5. PubMed ID: 16304731
    [No Abstract]   [Full Text] [Related]  

  • 45. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychedelic pleasures: An affective understanding of the joys of tripping.
    Bøhling F
    Int J Drug Policy; 2017 Nov; 49():133-143. PubMed ID: 28918193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Set, setting, and matrix.
    Eisner B
    J Psychoactive Drugs; 1997; 29(2):213-6. PubMed ID: 9250949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Survey of American Psychiatrists' Attitudes Toward Classic Hallucinogens.
    Barnett BS; Siu WO; Pope HG
    J Nerv Ment Dis; 2018 Jun; 206(6):476-480. PubMed ID: 29781894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists.
    Berger JJ; Fitzgerald PB
    Australas Psychiatry; 2023 Apr; 31(2):190-194. PubMed ID: 36779819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychedelics: A New Treatment Paradigm in Psychiatry?
    Gründer G
    Pharmacopsychiatry; 2021 Jul; 54(4):149-150. PubMed ID: 34169501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health.
    Barnett BS
    J Psychopharmacol; 2022 Oct; 36(10):1097-1099. PubMed ID: 36112818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research on psychedelic substances.
    Brandt SD; Passie T
    Drug Test Anal; 2012; 4(7-8):539-42. PubMed ID: 22767470
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevalence and epidemiological associates of novel psychedelic use in the United States adult population.
    Sexton JD; Crawford MS; Sweat NW; Varley A; Green EE; Hendricks PS
    J Psychopharmacol; 2019 Sep; 33(9):1058-1067. PubMed ID: 30816808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A role for psychedelics in psychiatry?
    Read T
    Br J Psychiatry; 2005 Nov; 187():483-4; author reply 484-5. PubMed ID: 16260827
    [No Abstract]   [Full Text] [Related]  

  • 56. Putting 'addiction' back into psychiatry: the RANZCP Section of Addiction Psychiatry.
    Lubman D; Jurd S; Baigent M; Krabman P
    Australas Psychiatry; 2008 Feb; 16(1):39-43. PubMed ID: 18202932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychedelic Medicines in Major Depression: Progress and Future Challenges.
    Bouso JC; Ona G; Dos Santos RG; Hallak JEC
    Adv Exp Med Biol; 2021; 1305():515-533. PubMed ID: 33834416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.
    Chi T; Gold JA
    J Neurol Sci; 2020 Apr; 411():116715. PubMed ID: 32044687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
    Vollenweider FX; Kometer M
    Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.
    Kozlowska U; Nichols C; Wiatr K; Figiel M
    J Neurochem; 2022 Jul; 162(1):89-108. PubMed ID: 34519052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.